GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grifols SA (MEX:GRF N) » Definitions » Cyclically Adjusted Book per Share

Grifols (MEX:GRF N) Cyclically Adjusted Book per Share : MXN0.00 (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Grifols Cyclically Adjusted Book per Share?

Note: As Cyclically Adjusted Book per Share is a main component used to calculate Cyclically Adjusted PB Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Grifols's adjusted book value per share for the three months ended in Dec. 2024 was MXN188.844. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is MXN0.00 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Grifols's average Cyclically Adjusted Book Growth Rate was 8.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 9.90% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 11.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Grifols was 13.00% per year. The lowest was 9.90% per year. And the median was 11.80% per year.

As of today (2025-07-08), Grifols's current stock price is MXN0.00. Grifols's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 was MXN0.00. Grifols's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Grifols was 7.99. The lowest was 1.07. And the median was 2.96.


Grifols Cyclically Adjusted Book per Share Historical Data

The historical data trend for Grifols's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grifols Cyclically Adjusted Book per Share Chart

Grifols Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Grifols Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23 Jun24 Sep24 Dec24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Grifols's Cyclically Adjusted Book per Share

For the Drug Manufacturers - General subindustry, Grifols's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grifols's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grifols's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Grifols's Cyclically Adjusted PB Ratio falls into.


;
;

Grifols Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Grifols's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book= Book Value per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=188.844/124.7533*124.7533
=188.844

Current CPI (Dec. 2024) = 124.7533.

Grifols Quarterly Data

Book Value per Share CPI Adj_Book
201403 42.238 100.139 52.620
201406 57.394 101.081 70.835
201409 46.372 100.441 57.597
201412 70.719 100.251 88.003
201503 75.569 99.474 94.773
201506 79.097 101.138 97.566
201509 88.744 99.559 111.202
201512 90.328 100.268 112.386
201603 92.327 98.638 116.772
201606 103.596 100.333 128.810
201609 112.136 99.737 140.263
201612 118.529 101.842 145.194
201703 112.307 100.896 138.862
201706 106.389 101.848 130.315
201709 113.421 101.524 139.373
201712 123.449 102.975 149.558
201803 121.402 102.122 148.307
201806 133.197 104.165 159.524
201809 132.317 103.818 158.999
201812 138.050 104.193 165.291
201903 141.006 103.488 169.981
201906 139.397 104.612 166.236
201909 151.652 103.905 182.081
201912 147.704 105.015 175.466
202003 209.818 103.469 252.979
202006 203.718 104.254 243.774
202009 203.247 103.521 244.934
202012 180.589 104.456 215.680
202103 193.132 104.857 229.777
202106 182.670 107.102 212.775
202112 188.692 111.298 211.504
202206 198.277 118.044 209.546
202209 0.000 117.221 0.000
202212 171.955 117.650 182.337
202306 160.490 120.278 166.461
202309 167.728 121.343 172.443
202312 146.331 121.300 150.497
202406 162.279 124.409 162.729
202409 171.831 123.121 174.110
202412 188.844 124.753 188.844

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Grifols  (MEX:GRF N) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Grifols was 7.99. The lowest was 1.07. And the median was 2.96.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Grifols Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Grifols's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Grifols Business Description

Industry
Address
Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Grifols Headlines

No Headlines